rs141658242
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005379.4(MYO1A):āc.49G>Cā(p.Glu17Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000598 in 1,614,164 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0031 ( 4 hom., cov: 32)
Exomes š: 0.00034 ( 1 hom. )
Consequence
MYO1A
NM_005379.4 missense
NM_005379.4 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
MYO1A (HGNC:7595): (myosin IA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional skeletal muscle myosin-1 (MYH1). Unconventional myosins contain the basic domains characteristic of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with autosomal dominant deafness. Alternatively spliced variants have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012277007).
BP6
Variant 12-57048275-C-G is Benign according to our data. Variant chr12-57048275-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 45312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 475 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO1A | NM_005379.4 | c.49G>C | p.Glu17Gln | missense_variant | 2/28 | ENST00000300119.8 | NP_005370.1 | |
MYO1A | NM_001256041.2 | c.49G>C | p.Glu17Gln | missense_variant | 3/29 | NP_001242970.1 | ||
MYO1A | XM_047428876.1 | c.49G>C | p.Glu17Gln | missense_variant | 3/29 | XP_047284832.1 | ||
MYO1A | XM_011538373.3 | c.49G>C | p.Glu17Gln | missense_variant | 2/25 | XP_011536675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO1A | ENST00000300119.8 | c.49G>C | p.Glu17Gln | missense_variant | 2/28 | 1 | NM_005379.4 | ENSP00000300119 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00309 AC: 471AN: 152186Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
471
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000738 AC: 185AN: 250828Hom.: 0 AF XY: 0.000546 AC XY: 74AN XY: 135516
GnomAD3 exomes
AF:
AC:
185
AN:
250828
Hom.:
AF XY:
AC XY:
74
AN XY:
135516
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000336 AC: 491AN: 1461860Hom.: 1 Cov.: 32 AF XY: 0.000300 AC XY: 218AN XY: 727236
GnomAD4 exome
AF:
AC:
491
AN:
1461860
Hom.:
Cov.:
32
AF XY:
AC XY:
218
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00312 AC: 475AN: 152304Hom.: 4 Cov.: 32 AF XY: 0.00287 AC XY: 214AN XY: 74466
GnomAD4 genome
AF:
AC:
475
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
214
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
52
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
116
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Glu17Gln in Exon 02 of MYO1A: This variant is not expected to have clinical sign ificance because it has been identified in 1.3% (48/3738) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs141658242). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;.
Polyphen
D;D;.
Vest4
MVP
MPC
0.45
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at